Ending the Evidentiary & Insurance Reimbursement Bias Against Neurofeedback to Treat ADHD: It Will Take Clinician Action in Addition to the Compelling Science

Autores/as

  • H. Edmund Pigott
  • Eugenia Bodenhamer-Davis
  • Richard E. Davis
  • Henry Harbin

DOI:

https://doi.org/10.1080/10874208.2013.785178

Resumen

no abstract

Descargas

Publicado

2016-08-23

Número

Vol. 17 Núm. 2 (2013)

Sección

EDITORIAL

Licencia

© International Society for Neurofeedback and Research (ISNR), all rights reserved. This article (the “Article”) may be accessed online from ISNR at no charge. The Article may be viewed online, stored in electronic or physical form, or archived for research, teaching, and private study purposes. The Article may be archived in public libraries or university libraries at the direction of said public library or university library. Any other reproduction of the Article for redistribution, sale, resale, loan, sublicensing, systematic supply, or other distribution, including both physical and electronic reproduction for such purposes, is expressly forbidden. Preparing or reproducing derivative works of this article is expressly forbidden. ISNR makes no representation or warranty as to the accuracy or completeness of any content in the Article.  From 1995 to 2013 the Journal of Neurotherapy was the official publication of ISNR (www. Isnr.org); on April 27, 2016 ISNR acquired the journal from Taylor & Francis Group, LLC. In 2014, ISNR established its official open-access journal NeuroRegulation (ISSN: 2373-0587; www.neuroregulation.org).